Author

Greatjoy Mazibuko

Observed names: G. Mazibuko, Greatjoy Njabulo Mazibuko

Institutions: United States Agency for International Development, Management Sciences for Health

Observed institutions: United States Agency for International Development, Management Sciences for Health

OpenAlex ID: A5048801047

Digital health technologies to support access to medicines and pharmaceutical services in the achievement of sustainable development goals

2018 · Niranjan Konduri, Francis Aboagye-Nyame, et al. · Digital Health · 34

Implementing an Integrated Pharmaceutical Management Information System for Antiretrovirals and Other Medicines: Lessons From Namibia

2018 · David Mabirizi, Bayobuya Phulu, et al. · Global Health Science and Practice · 28

Assessment of the World Health Organization’s HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia

2016 · Nicholus Mutenda, Alexandra Bukowski, et al. · PLoS ONE · 16

Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost–Utility Analysis

2016 · Marita Mann, Assegid Mengistu, et al. · Drug Safety · 14

Sentinel site active surveillance of safety of first-line antiretroviral medicines in Namibia

2016 · Marita Mann, Assegid Mengistu, et al. · Pharmacoepidemiology and Drug Safety · 5

Incorporating pharmaceutical supply management modules in the pre-service curriculum of the BPharm program, of the University of Namibia, School of Pharmacy

2014 · Greatjoy Njabulo Mazibuko, Evans Sagwa, et al. · Journal of Pharmaceutical Policy and Practice · 3

Sentinel site active Surveillance of the safety of first-line Antiretroviral medicines in Namibia

2015 · M. Mann, A. Mengistu, et al. · Value in Health

Factors contributing to patients on anti-retroviral therapy defaulting on treatment in Oshakati hospital in Namibia

2008 · Greatjoy Mazibuko · UNAM Scholarly Repository (University of Namibia)

Works count: 11

Citation count: 100

H-index: 5

I10-index: 4